Table 1. Incidence of Poor Outcomes in Immunosuppressed and Immunocompetent Patients Stratified by Number of Squamous Cell Carcinoma (SCC) Tumorsa.
| SCCs, No. | Patients, No. (%) | LR | NM | ITM | Any PO | ||||
|---|---|---|---|---|---|---|---|---|---|
| No. (%) | P Value | No. (%) | P Value | No. (%) | P Value | No. (%) | P Value | ||
| Immunosuppressed cases | |||||||||
| 1 | 46 (43.4) | 2 (4.3) | 1 [Reference] | 2 (4.3) | 1 [Reference] | 2 (4.3) | 1 [Reference] | 4 (8.7) | 1 [Reference] |
| 2-9 | 47 (44.3) | 14 (29.8) | .001 | 3 (6.4) | >.99 | 3 (6.4) | >.99 | 15 (31.9) | <.001 |
| ≥10 | 13 (12.3) | 9 (69.2) | <.001 | 1 (7.7) | .53 | 0 | >.99 | 9 (69.2) | <.001 |
| Immunocompetent controls | |||||||||
| 1 | 159 (75.0) | 13 (8.2) | 1 [Reference] | 1 (0.6) | 1 [Reference] | 2 (1.3) | 1 [Reference] | 13 (8.2) | 1 [Reference] |
| 2-9 | 53 (25.0) | 2 (4.0) | .37 | 0 | >.99 | 0 | >.99 | 2 (4.0) | .37 |
| ≥10 | 0 | NA | NA | NA | NA | NA | NA | NA | NA |
Abbreviations: ITM, in-transit metastases; LR, local recurrence; NA, not applicable; NM, nodal metastases; PO, poor outcomes.
a
Fisher exact statistics were used when cell sample size was fewer than 5.